Pressure BioSciences Added to the High-Performing Richmond Club
Index; Richmond Index Has Outperformed the S&P 500
Index by an Average of 11% Each Year for the Past Ten
Years
Company to Present Business Overview to Over 500 Investor Members
on April 13th
South Easton, MA -- April 12, 2016 -- InvestorsHub NewsWire
-- Pressure BioSciences, Inc. (OTCQB:
PBIO) (PBI and the Company), a leader in the development and
sale of broadly enabling pressure cycling technology (PCT)-based
sample preparation solutions to the worldwide life sciences
industry, today announced it has been added to the Richmond Club
Index, which has outperformed the S&P 500 Index by an average
of 11% each year since its inception ten years ago. The Richmond
Club boasts roughly 550 members, comprised of a mix of investment
advisors, fund managers, analysts, and members of the media.
Inclusion in the Richmond Club Index is difficult to achieve. To
be invited, the Richmond Club initially screens thousands of
publicly-traded companies, chooses a few to interview, then selects
the best company among the finalists that it believes is the most
undervalued relative to its peers, and also offers excellent growth
potential.
Mr. Scott Barber, President of the Richmond Club, commented: We
believe there are two primary reasons for the Richmond Club Indexs
success to date: (i) we carefully select only top quality,
undervalued, high growth potential companies to add to the Index,
and (ii) we have been highly successful in expanding the
shareholder base of selected companies by showcasing them to our
expanding base of investors, now at nearly 550 members. This added
investor exposure tends to increase the liquidity of the selected
companys stock, while putting upward pressure on the price.
Mr. Richard T. Schumacher, President and CEO of PBI, said: We
are very pleased that Pressure BioSciences has been selected for
addition into the Richmond Club Index. It is most impressive that
the Index has outperformed the S&P 500 Index over the past ten
years while expanding the shareholder base of Index companies. We
are particularly delighted by the exposure that PBI will be getting
to the Richmond Clubs 500-plus members, comprised of an assortment
of investors and investing professionals, many of whom will be
hearing the PBI story for the first time. This new investor
recognition, building upon PBIs recent growth momentum together
with important financial, strategic marketing, and new product
achievements, lead us to believe that 2016 will be our most
successful year to date.
About Pressure BioSciences Presentation to the Richmond Club
PBI will present a business overview to the Richmond Clubs
members on Wednesday, April 13 and again in approximately six
months. PBIs presentation will take place at the centrally located
National Club, which is two blocks from the Toronto Stock Exchange.
To get the PBI story out to the roughly 550 Richmond Club members,
a video will be taken of Mr. Schumacher and synchronized with the
Companys PowerPoint slides. This will allow investors on the
internet to hear and see exactly what is observed by the live
audience. A link to the video will be emailed to all members within
five days of the presentation. Internet web statistics show that
each video is seen 300-500 times over the first thirty days of the
video being posted on the Richmond Club website.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) (OTCQB: PBIO) develops,
markets, and sells proprietary laboratory instrumentation and
associated consumables to the estimated $6 billion life sciences
sample preparation market. Our products are based on the unique
properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or PCT) hydrostatic pressure. PCT is a
patented enabling technology platform that uses alternating cycles
of hydrostatic pressure between ambient and ultra-high levels to
safely and reproducibly control bio-molecular interactions. To
date, we have installed nearly 300 PCT systems in approximately 160
sites worldwide. There are over 100 publications citing the
advantages of the PCT platform over competitive methods, many from
key opinion leaders. Our primary application development and sales
efforts are in the biomarker discovery and forensics areas.
Customers also use our products in other areas, such as drug
discovery & design, bio-therapeutics characterization, soil
& plant biology, vaccine development, histology, and forensic
applications.
About The Richmond Club and the Richmond Club Index
The Richmond Club is celebrating its 17th year of helping its
roughly 550 members to profit from investing in the Clubs Index of
top quality, undervalued, high growth potential companies. Richmond
Club members are a mix of investment advisors, fund managers,
analysts, and members of the media. Companies in the Richmond Club
Index are invited to make a presentation every six months (twice
over the twelve month term). To cover the costs of the investor
luncheon presentations, video production and web promotion, PBI has
agreed to pay Streetwise Investors Club, Inc., owner of the
Richmond Club, $1,450 U.S. per month for the twelve month term that
PBI will be in the Richmond Club Index.
Forward Looking Statements
This press release contains forward-looking statements. These
statements relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and
other factors that may cause our or our industry's actual results,
levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance
or achievements expressed, implied or inferred by these
forward-looking statements. In some cases, you can identify
forward-looking statements by terminology such as "may," "will,"
"should," "could," "would," "expects," "plans," "intends,"
"anticipates," "believes," estimates," "predicts," "projects,"
"potential" or "continue" or the negative of such terms and other
comparable terminology. These statements are only predictions based
on our current expectations and projections about future events.
You should not place undue reliance on these statements. In
evaluating these statements, you should specifically consider
various factors. Actual events or results may differ materially.
The Company's financial results for the year ended December 31,
2015 may not necessarily be indicative of future results. These and
other factors may cause our actual results to differ materially
from any forward-looking statement. These risks, uncertainties, and
other factors include, but are not limited to, the risks and
uncertainties discussed under the heading "Risk Factors" in the
Company's Annual Report on Form 10-K for the year ended December
31, 2015, and other reports filed by the Company from time to time
with the SEC. The Company undertakes no obligation to update any of
the information included in this release, except as otherwise
required by law.
For more information about PBI and this press release, please
click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Twitter | LinkedIn | YouTube | Google+ | Facebook
Richard T. Schumacher, President & CEO (508) 230-1828
(T)
Jeffrey N. Peterson, Chairman of the Board (650) 812-8121
(T)